Fractyl Health Files Q1 2025 10-Q
Ticker: GUTS · Form: 10-Q · Filed: May 13, 2025 · CIK: 1572616
| Field | Detail |
|---|---|
| Company | Fractyl Health, Inc. (GUTS) |
| Form Type | 10-Q |
| Filed Date | May 13, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, medical-devices
TL;DR
Fractyl Health 10-Q filed. Financials updated for Q1 2025. Check convertible debt & retained earnings.
AI Summary
Fractyl Health, Inc. filed its quarterly report on Form 10-Q for the period ending March 31, 2025. The company's principal executive offices are located at 3 Van De Graaff Drive, Suite 200, Burlington, MA 01803. The filing indicates the company's fiscal year ends on December 31st. Key financial elements such as convertible debt and retained earnings are noted for the reporting period.
Why It Matters
This filing provides investors with an update on Fractyl Health's financial performance and position as of March 31, 2025, which is crucial for understanding the company's ongoing operations and potential.
Risk Assessment
Risk Level: medium — Quarterly reports can reveal significant financial shifts or operational challenges that may impact a company's stock price.
Key Numbers
- 1231 — Fiscal Year End (Indicates the company's annual financial reporting cycle.)
- 20250331 — Reporting Period End Date (Marks the end of the financial quarter covered by the report.)
Key Players & Entities
- FRACTYL HEALTH, INC. (company) — Filer of the 10-Q report
- 3 VAN DE GRAAFF DRIVE, SUITE 200, BURLINGTON, MA 01803 (location) — Company's business and mailing address
- 20250331 (date) — End of the reporting period for the 10-Q
- 0000950170-25-070275 (filing_id) — Accession number for the SEC filing
FAQ
What is the company's primary business as indicated by its SIC code?
The company's Standard Industrial Classification (SIC) code is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
When was the company formerly known as Fractyl Laboratories Inc.?
The company's name changed from Fractyl Laboratories Inc. on March 20, 2013.
What are some of the financial elements reported for the period ending March 31, 2025?
The filing references us-gaap:ConvertibleDebtMember and us-gaap:RetainedEarningsMember for the period of 2025-01-01 to 2025-03-31.
What is the filing date of this 10-Q report?
This 10-Q report was filed on May 13, 2025.
What are the details of the 'Two Thousand And Twenty Four Incentive Award Plan' mentioned?
The 'Two Thousand And Twenty Four Incentive Award Plan' is referenced with dates such as January 26, 2024, and periods like January 1, 2024, to June 30, 2024, indicating its adoption and operational timeframe.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 13, 2025 regarding FRACTYL HEALTH, INC. (GUTS).